Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

NEFL mRNA expression level is a prognostic factor for early-stage breast cancer patients.

Li XQ, Li L, Xiao CH, Feng YM.

PLoS One. 2012;7(2):e31146. doi: 10.1371/journal.pone.0031146. Epub 2012 Feb 2.

2.

Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer.

Li X, Cao X, Li X, Zhang W, Feng Y.

Cancer Sci. 2007 Oct;98(10):1592-6. Epub 2007 Jul 25.

3.

ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer.

Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Kawaguchi M, Miura Y, Iwase H.

Clin Cancer Res. 2005 Jan 1;11(1):193-8.

4.

Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.

Nakamura Y, Yasuoka H, Tsujimoto M, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K.

Breast Cancer Res Treat. 2005 May;91(2):125-32.

PMID:
15868440
5.

[Claudins as prognostic factors of breast cancer].

Szász MA.

Magy Onkol. 2012 Sep;56(3):209-12. doi: MagyOnkol.2012.56.3.209. Epub 2012 Jul 2. Hungarian.

6.

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.

Spataro VJ, Litman H, Viale G, Maffini F, Masullo M, Golouh R, Martinez-Tello FJ, Grigolato P, Shilkin KB, Gusterson BA, Castiglione-Gertsch M, Price K, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Collins J, Gelber RD, Coates AS, Goldhirsch A; International Breast Cancer Study Group.

Cancer. 2003 Apr 1;97(7):1591-600.

7.
8.

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer.

Radke I, Götte M, Kersting C, Mattsson B, Kiesel L, Wülfing P.

Br J Cancer. 2006 Aug 7;95(3):347-54. Epub 2006 Jul 11.

9.

Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?

Falck AK, Fernö M, Bendahl PO, Rydén L.

World J Surg. 2010 Jul;34(7):1434-41. doi: 10.1007/s00268-010-0499-z.

PMID:
20213203
10.

Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.

Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, Ning L, Fang Z, Wang Y, Zhang L, Cheng J, Zhang W, Hao X.

Breast Cancer Res Treat. 2007 Jul;103(3):319-29. Epub 2006 Nov 23. Erratum in: Breast Cancer Res Treat. 2007 May;103(1):125-7.

PMID:
17123152
11.

mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.

Marchetti A, Buttitta F, Bertacca G, Zavaglia K, Bevilacqua G, Angelucci D, Viacava P, Naccarato A, Bonadio A, Barassi F, Felicioni L, Salvatore S, Mucilli F.

J Pathol. 2001 Sep;195(2):186-90.

PMID:
11592097
12.

Role of neurofilament light polypeptide in head and neck cancer chemoresistance.

Chen B, Chen J, House MG, Cullen KJ, Nephew KP, Guo Z.

Mol Cancer Res. 2012 Mar;10(3):305-15. doi: 10.1158/1541-7786.MCR-11-0300. Epub 2012 Jan 13.

13.

CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.

Tunca B, Egeli U, Cecener G, Tezcan G, Gökgöz S, Tasdelen I, Bayram N, Tolunay S, Umut G, Demirdogen E, Erturk E, Ak S, Cetintas S, Evrensel T.

Tumori. 2012 Mar-Apr;98(2):243-51. doi: 10.1700/1088.11937.

PMID:
22677992
14.

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Apr 12;7:63.

15.

Association of angiogenesis in lymph node metastases with outcome of breast cancer.

Guidi AJ, Berry DA, Broadwater G, Perloff M, Norton L, Barcos MP, Hayes DF.

J Natl Cancer Inst. 2000 Mar 15;92(6):486-92.

16.

Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.

Wu K, Quan Z, Weng Z, Li F, Zhang Y, Yao X, Chen Y, Budman D, Goldberg ID, Shi YE.

Breast Cancer Res Treat. 2007 Mar;101(3):259-67. Epub 2006 Jul 4.

PMID:
16821081
17.

The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues.

Yao Q, Chen J, Lv Y, Wang T, Zhang J, Fan J, Wang L.

Tumour Biol. 2011 Dec;32(6):1163-71. doi: 10.1007/s13277-011-0219-9. Epub 2011 Aug 23.

PMID:
21861179
18.

Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.

Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H.

Clin Cancer Res. 2006 Nov 1;12(21):6410-4.

19.

Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.

Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R.

Oncol Rep. 2012 Jun;27(6):1759-64. doi: 10.3892/or.2012.1709. Epub 2012 Mar 7.

PMID:
22407237
20.

[Expression and clinical significance of KNSL4 in breast cancer].

Feng YM, Wan YF, Li XQ, Cao XC, Li X.

Ai Zheng. 2006 Jun;25(6):744-8. Chinese.

PMID:
16764773
Items per page

Supplemental Content

Write to the Help Desk